You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1200 Leveraging the immunocompetent Vk*MYChCRBN model of multiple myeloma to determine and overcome T cell engager antibody resistance mechanisms

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1200 Leveraging the immunocompetent Vk*MYChCRBN model of multiple myeloma to determine and overcome T cell engager antibody resistance mechanisms

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202321208
Dec 20237608
Jan 20243503
Feb 20244204
Mar 20247007
Apr 20246006
May 20245606
Jun 20241600
Jul 20245003
Aug 20241004
Sep 20242000
Oct 20242609
Nov 20245405
Dec 2024805
Jan 202547013
Feb 20251006
Mar 2025008
Apr 2025003
May 2025006
Jun 2025103
Total7930107